Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 283 participants.

Also called NCT03775512

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 283 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03775512
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03775512. Non-randomized; no masking; primary purpose treatment. Start 2019-01-30 (actual); primary completion 2022-02-17 (actual). Results posted on 2023-03-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation
Acronym
Q-FFICIENCY
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
RF Ablation with QDOT Micro
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03775512
Content hash
3737184662e213058fe06f679e628f9ac45dd58946d71f0db9e3e80311d399cb